Likewise, breast cancer cells engineered to overexpress a mutant c-fos, unable to bind the AP-1 sites, failed to induce the up-regulation of HIF-1α in response to estrogen [165], thus supporting the involvement of the transcription factor c-fos in the transcriptional activation of HIF-1α gene. The gene discussed is FOS; the disease is breast cancer.